Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
48
open positions at argenx
View Full Profile
Project Manager Preclinical Product Development
argenx
Posted 3d ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
MANAGER
H-1B · 1 FY23
Director, Employee Communications & Engagement – Global Commercialization
argenx
Posted 3d ago
Boston, MA, USA
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Communications
Immunology
Executive
H-1B · 1 FY23
Territory Business Manager- Buffalo, NY
argenx
Posted 5d ago
Buffalo
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Neurology
MANAGER
H-1B · 1 FY23
Key Account Manager, Brazil (São Paolo)
argenx
Posted 6d ago
Brazil - Field
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Key Account Manager, Brazil (Cruitiba)
argenx
Posted 6d ago
Brazil - Field
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Key Account Manager, Brazil (Recife)
argenx
Posted 6d ago
Brazil - Field
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Medical Science Liaison (Northwest)
argenx
Posted 6d ago
United States - Field; Seattle; Portland, OR
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
DT Business Lead - Research
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
Senior
H-1B · 1 FY23
DT Strategic Partnerships Lead
argenx
Posted 1w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Business Development
Immunology
Senior
H-1B · 1 FY23
Device Expert Director, Technical Operations
argenx
Posted 1w ago
Remote
$188K - $259K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Territory Business Manager, Green Bay Wisconsin
argenx
Posted 2w ago
Green Bay
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Digital Technology Product Owner, US Market Access
argenx
Posted 2w ago
Boston, MA, USA
$156K - $215K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MID
H-1B · 1 FY23
Digital Technology Product Owner, US HCP Experience
argenx
Posted 2w ago
Boston, MA, USA
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Medical Science Liaison, Multi-Specialty (Northeast or Southeast)
argenx
Posted 2w ago
United States - Field
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Medical Science Liaison, Multi-Specialty
argenx
Posted 2w ago
Minneapolis; St Louis
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Senior Scientist DP Commercial
argenx
Posted 2w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
Senior
H-1B · 1 FY23
Medical Science Liaison - Houston and Austin
argenx
Posted 2w ago
Houston
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Medical Science Liaison, Multi-Specialty (Central)
argenx
Posted 2w ago
United States - Field
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Associate Director, US Commercial Insights - Rheumatology
argenx
Posted 3w ago
Remote
$168K - $231K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Commercial
Immunology
Executive
H-1B · 1 FY23
Regional Pharmacovigilance Lead (US)
argenx
Posted 3w ago
United States
$192K - $264K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Pharmacovigilance
Immunology
Senior
H-1B · 1 FY23
1
2
3
Next
Company Overview
Active Jobs
48
Pipeline Programs
86
Drug Products
2
Clinical Trials
89
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Hematology
Rare Diseases